APeX Global Disease Research Institute (Los Angeles, CA)

Name

  • Name:Geoffrey Daniel
  • Title:Grant application writer

Organization Address

  • Organization Name:APeX Global Disease Research Institute
  • Address:1875 Oak Tree Drive
    Los Angeles, CA 90041
    United States

Organization Phone

  • Main phone:3238672004
  • Main fax:3233914350

Organization Web

User Email

Location

Click map for a full size active view.

General

  • Mission:
  • Our mission is to eliminate world-wide suffering and economic loss from cancer.

    We believe we can revolutionize cancer treatment - both its effectiveness and economics - by making our inexpensive APeX product readily available to all.

    Our Pay It Forward business model for the delivery of APeX is also revolutionary, in that it aims to provide APeX at no cost to those who otherwise could not afford it.

    The APeX mission is actually much broader than addressing only cancer, in that APeX is effective against probably all non-aerobic pathogens, of which cancer is merely the best known and most infamous example.

  • Overview:
  • APeX is a proprietary product invented by the organization's owners.

    In general, APeX can be said to be a potent destroyer of anaerobic pathogens, including cancer - the most notorious example of a pathogen.

    The word "APeX" stands for Anti-Pathogen to the eXtreme. A scientist contracted to examine the product declared that it is a unique, new molecule that acts as "a non-toxic autonomously intelligent hunter-killer cancer smart bomb that seeks out and destroys all types of cancer cells regardless of their genomic profile, without chemo or toxins and with no collateral damage or adverse effects." He added that, "APeX Is unlike anything else in molecular structure I’ve ever seen. It’s a Fundamental Scientific Breakthrough – a Medical Game Changer."

    APeX' ability to cure or substantially ameliorate cancers and other diseases has been demonstrated in a fairly large number of so-called "anecdotal" cases over the last fourteen years.

    Going even further, however, over a period of five years during which an ICAM (Integrated Complementary & Alternative Medicine) study of APeX was conducted, irrefutable documentary evidence was found in patients' hard-copy medical records showing that APeX was the primary if not sole reason for the disease's elimination ("resolution") or reduction in a large number of these cases.

    The APeX Global Disease Research Institute is satisfied that the APeX product can do what they believe it can, and now wishes to proceed, in cooperation with FDA regulations, to prove APeX' efficacy against cancers and other anaerobic pathogens using the FDA's fast-track and related clinical validation procedures.

    Even using the fast-track procedures, clinical validation is horrendously expensive, and the sum of $1M is estimated to be the minimum needed to cover those validation costs plus the cost of bringing APeX production capacity up to the level needed for that testing and the market launch thereafter.

    This grant application is designed to assist in raising the needed $1M.

  • History:
  • The APeX product was an accidental discovery many years ago, when an earlier version of the product was found to "miraculously" cure some cancers and other serious diseases when drunk in an aqueous solution.

    Reflection on the product's efficacy later resulted in a determined effort to come up with an enhanced version - the current APeX, in which it was discovered how to append multiple oxygen atoms to a single silver atom, resulting in a substance that both seeks out cancer or other anaerobic pathogens then delivers a knock-out blow to the target cell, totally destroying it!

    The results on the increasing numbers of people being attracted to APeX made it clear that some validation of the product's effectiveness was essential, so the inventors decided that they would require users to provide before and after medical records then let the results speak for themselves.

    This was particularly important, in light of the Federal Drug Administration (FDA)'s prohibition of unverified claims for diagnosing, treating, curing or ameliorating disease.

    As a result of this decision, the institute now has a substantial database of provable medical records demonstrating APeX' validity, or its "likely" validity for the purpose of getting FDA-approved fast-track clinical testing started.

    We're now at the point where the rubber hits the road, as they say, and the needed financial resources must be forthcoming to fund the FDA testing and the production of sufficient quantities of APeX.

    The Institute operates as a tax-exempt nonprofit agency under the group nonprofit license of Vision Christian Minstries, Inc., EIN: 59-3362021, whose mission is, "We reach out to people of all ages and needs with the Lord's help."

  • Year established:2008
  • Endowment:Unknown

Staff

  • Executive / Trustee board size:3
  • Advisory board size:0
  • Staff size:4

Registration

  • Organization type:Grantseeker
  • Country of registration:United States
  • Tax Determination Letter:Received Determination Letter
  • IRS Section:501(c)(3)
  • IRS Subsection:None
  • Tax ID:59-3362021

Other Organization Web

IRS Business Master File Information

  • EIN:593362021
  • Organization Name:VISION CHRISTIANS MINISTRIES INC
  • Sort (Secondary) Name:
  • Care Of Name:
  • Organization Address:12181 FORT CAROLINE RD
  • Organization City:JACKSONVILLE
  • Organization State:FL
  • Organization Zip:32225-1617
  • Group Exemption Number:8068
  • Subsection Code:03
  • Classification Code(s):7
  • Subsection/Classification Desc.:Religious Organization
  • Affiliation Code:8
  • Ruling Date:February, 1997
  • Deductibility Code:1
  • Foundation Code:10
  • Foundation Code Desc.:Church 170(b)(1)(A)(i)
  • Activity Code(s):001
  • Activity Code Desc.(s):Church, synagogue, etc
  • Organization Code:1 (Corporation)
  • Exempt Org. Status Code:01 (Unconditional Exemption)
  • Tax Period:December, 1969
  • Filing Requirement Category:06 (990 - Not required to file (church))
  • Accounting Period:December
  • NTEE Code:X20Z
  • Asset Amount:$0
  • Asset Code:
  • Income Amount:$0
  • Income Code:
  • 990 Revenue Amount:$0
  • Last Updated:2/20/2018 11:12:10 pm

This information is directly from the IRS Exempt Organization Business Master File at Exempt Organizations Business Master File Extract. This information is not under the control of the Common Grant Application and is collected and compiled and can only be changed by the IRS.